These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6809724)

  • 1. Isolation and identification of althiomycin from Cystobacter fuscus (myxobacterales).
    Kunze B; Reichenbach H; Augustiniak H; Höfle G
    J Antibiot (Tokyo); 1982 May; 35(5):635-6. PubMed ID: 6809724
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus.
    Ojika M; Suzuki Y; Tsukamoto A; Sakagami Y; Fudou R; Yoshimura T; Yamanaka S
    J Antibiot (Tokyo); 1998 Mar; 51(3):275-81. PubMed ID: 9589062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural elucidation of the two positional isomers of a mono-glucopyranosyl mono-acyl glycerol derivative from Cystobacter fuscus (Myxobacterales).
    Scherer OW; Budzikiewicz H; Hartmann R; Klein RA; Egge H
    Biochim Biophys Acta; 1992 Jul; 1117(1):42-6. PubMed ID: 1627591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties.
    Irschik H; Gerth K; Kemmer T; Steinmetz H; Reichenbach H
    J Antibiot (Tokyo); 1983 Jan; 36(1):6-12. PubMed ID: 6432761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales).
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1982 Nov; 35(11):1454-9. PubMed ID: 6819280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drugs that influence eucaryotic motile processes on motility of Cystobacter fuscus (Myxobacterales).
    Heumann HG; Kühlwein H
    Z Allg Mikrobiol; 1979; 19(8):547-52. PubMed ID: 232592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization.
    Onishi N; Izaki K; Takahashi H
    J Antibiot (Tokyo); 1984 Jan; 37(1):13-9. PubMed ID: 6421789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of cystothiazole A, a myxobacterial antibiotic, into novel derivatives by the mother producer, Cystobacter fuscus.
    Suzuki Y; Ojika M; Sakagami Y
    Biosci Biotechnol Biochem; 2004 Feb; 68(2):390-6. PubMed ID: 14981303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiangazole, a new thiazoline antibiotic from Polyangium sp. (myxobacteria): production, antimicrobial activity and mechanism of action.
    Kunze B; Jansen R; Pridzun L; Jurkiewicz E; Hunsmann G; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1993 Nov; 46(11):1752-5. PubMed ID: 8270498
    [No Abstract]   [Full Text] [Related]  

  • 10. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
    Kunze B; Kohl W; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roimatacene: an antibiotic against Gram-negative bacteria isolated from Cystobacter ferrugineus Cb G35 (Myxobacteria).
    Zander W; Gerth K; Mohr KI; Kessler W; Jansen R; Müller R
    Chemistry; 2011 Jul; 17(28):7875-81. PubMed ID: 21618624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of althiomycin.
    Kirst HA; Szymanski EF; Dorman DE; Occolowitz JL; Jones ND; Chaney MO; Hamill RL; Hoehn MM
    J Antibiot (Tokyo); 1975 Apr; 28(4):286-91. PubMed ID: 1150528
    [No Abstract]   [Full Text] [Related]  

  • 14. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
    Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a bacterial artificial chromosome library for a myxobacterium of the genus Cystobacter and characterization of an antibiotic biosynthetic gene cluster.
    Feng Z; Qi J; Tsuge T; Oba Y; Kobayashi T; Suzuki Y; Sakagami Y; Ojika M
    Biosci Biotechnol Biochem; 2005 Jul; 69(7):1372-80. PubMed ID: 16041144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.
    Vaks B; Zuckerberg A; Rosenberg E
    Can J Microbiol; 1974 Feb; 20(2):155-61. PubMed ID: 4362757
    [No Abstract]   [Full Text] [Related]  

  • 17. Indothiazinone, an indolyl thiazolyl ketone from a novel myxobacterium belonging to the Sorangiineae.
    Jansen R; Mohr KI; Bernecker S; Stadler M; Müller R
    J Nat Prod; 2014 Apr; 77(4):1054-60. PubMed ID: 24697522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystodienoic acid: a new diterpene isolated from the myxobacterium Cystobacter sp.
    Raju R; Mohr KI; Bernecker S; Herrmann J; Müller R
    J Antibiot (Tokyo); 2015 Jul; 68(7):473-5. PubMed ID: 25690355
    [No Abstract]   [Full Text] [Related]  

  • 19. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties.
    Kunze B; Kemmer T; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1984 May; 37(5):454-61. PubMed ID: 6429114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthetic studies on a myxobacterial antibiotic, cystothiazole A: biosynthetic precursors of the carbon skeleton.
    Suzuki Y; Sakagami Y; Ojika M
    J Antibiot (Tokyo); 2003 Apr; 56(4):372-8. PubMed ID: 12817811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.